Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) has been closed on 07 May 2025. It no longer accepts any bids. For further information, you can contact the National Institutes of Health
Bellow, you can find more information about this project: